577
Participants
Start Date
July 15, 2019
Primary Completion Date
March 20, 2023
Study Completion Date
September 30, 2025
Nivolumab
Nivolumab is an antibody directed at the programmed death receptor-1 (PD-1), blocking its interaction with PD-L1 and PD-L2.
Sitravatinib
Sitravatinib is a small molecule inhibitor of receptor tyrosine kinases.
Docetaxel
Docetaxel is an anti-neoplastic agent that acts by disrupting the microtubular network in cells.
Centre Hospitalier Universitaire Vaudois Lausanne, Lausanne
Local Institution - 005-454, Budapest
Local Institution - 005-457, Budapest
Local Institution - 005-455, Budapest
Hopitaux Universitaires de Geneve, Geneva
Local Institution - 005-456, Törökbálint
Local Institution - 005-206, Edegem
Local Institution - 005-450, Tatabánya
Local Institution - 005-201, Brasschaat
Inselspital Universitatsspital Bern, Bern
Local Institution - 005-200, Charleroi
Kantonsspital Winterthur, Winterthur
Local Institution - 005-453, Farkasgyepű
Local Institution - 005-205, Roeselare
Local Institution - 005-202, Ghent
Local Institution - 005-207, Ghent
Local Institution - 005-452, Győr
Local Institution - 005-204, Ronse
Local Institution - 005-451, Szombathely
Local Institution - 005-182, Lake Success
New York Cancer & Blood Specialists - Port Jefferson Medical Oncology, Port Jefferson Station
Local Institution - 005-107, Stony Brook
Local Institution - 005-301, Marseille
Local Institution - 005-312, Marseille
Local Institution - 005-418, Berlin
Local Institution - 005-123, Johnson City
Local Institution - 005-807, A Coruña
Local Institution - 005-612, Alessandria
Local Institution - 005-823, Santiago de Compostela
USOR - Alliance Cancer Specialists - Horsham (Abington Hematology Oncology Associates), Horsham
Local Institution - 005-186, Philadelphia
Local Institution - 005-606, Milan
Local Institution - 005-605, Monza
Local Institution - 005-303, Dijon
Ospedale di Circolo e Fondazione Macchi, Varese
Local Institution - 005-144, Charlottesville
Local Institution - 005-417, Grohansdorf
Local Institution - 005-805, Jaén
Virginia Cancer Institute - West End, Richmond
Local Institution - 005-405, Lübeck
Local Institution - 005-817, León
Hematology Oncology Associates of Fredericksburg, Fredericksburg
Local Institution - 005-611, Cremona
Local Institution - 005-812, Lugo
Hospital Universitario La Princesa, Madrid
Local Institution - 005-808, Madrid
Local Institution - 005-819, Madrid
Local Institution - 005-821, Madrid
Local Institution - 005-813, Madrid
Local Institution - 005-815, Madrid
Local Institution - 005-809, Madrid
Hospital Universitario La Paz, Madrid
Local Institution - 005-806, Majadahonda
Local Institution - 005-801, Málaga
Local Institution - 005-607, Piacenza
Local Institution - 005-307, Brest
Local Institution - 005-119, Marietta
Local Institution - 005-146, Atlanta
University Cancer & Blood Center (UCBC) - Athens, Athens
John B. Amos Cancer Center Research, Columbus
SCRI - Florida Cancer Specialists - Panhandle Research Office, Tallahassee
Local Institution - 005-104, Orlando
Local Institution - 005-803, Oviedo
Memorial Regional Hospital, Hollywood
Mount Sinai Health System, Miami Beach
Michael and Dianne Bienes Comprehensive Cancer Center, Fort Lauderdale
Local Institution - 005-154, West Palm Beach
SCRI - Florida Cancer Specialists - North Region Research Office, St. Petersburg
Watson Clinic Cancer and Research Center, Lakeland
Local Institution - 005-120, Fort Myers
Local Institution - 005-120E, Naples
Local Institution - 005-416, Kassel
Local Institution - 005-313, Montpellier
Local Institution - 005-079, Ocala
Local Institution - 005-816, Las Palmas de Gran Canaria
Local Institution - 005-164, Birmingham
Clearview Cancer Institute - Huntsville, Huntsville
Local Institution - 005-818, Vigo
Local Institution - 005-137A, Dickson
Local Institution - 005-137B, Dickson
Local Institution - 005-137C, Dickson
Local Institution - 005-137D, Dickson
Local Institution - 005-137E, Dickson
Local Institution - 005-137F, Dickson
Local Institution - 005-137G, Dickson
Local Institution - 005-137H, Dickson
Local Institution - 005-137I, Dickson
Local Institution - 005-137J, Dickson
Local Institution - 005-137K, Dickson
Local Institution - 005-137L, Dickson
Local Institution - 005-137M, Hendersonville
Local Institution - 005-137, Nashville
Local Institution - 005-195, Memphis
Jackson Oncology Associates - The Hederman Cancer Center, Jackson
Local Institution - 005-153, Louisville
Commonwealth Cancer Center - Frankfort, Danville
Local Institution - 005-600, Parma
Local Institution - 005-181, Columbus
Local Institution - 005-103, Toledo
Tricounty Hematology and Oncology - Massillon, Massillon
Local Institution - 005-196, Canton
Local Institution - 005-316, Saint-Herblain
Local Institution - 005-419, Essen
USOR - Oncology Hematology Care - Blue Ash, Cincinnati
IVO - Fundacion Instituto Valenciano de Oncologia, Valencia
Local Institution - 005-804, Valencia
Franciscan Health Cancer Center Indianapolis, Indianapolis
Local Institution - 005-122, Goshen
Fort Wayne Medical Oncology and Hematology - Fort Wayne South Office, Fort Wayne
Local Institution - 005-610, Meldola
Local Institution - 005-150, Lafayette
Barbara Ann Karmanos Cancer Institute, Detroit
Henry Ford Hospital, Detroit
Local Institution - 005-412, Cologne
Local Institution - 005-401, Bonn
Froedtert Hospital, Milwaukee
Local Institution - 005-116, Madison
ThedaCare Regional Cancer Center, Appleton
Local Institution - 005-414, Mainz
Local Institution - 005-127, Minneapolis
Local Institution - 005-609, Pisa
Sisters of Charity of Leavenworth Health St. Marys, Billings
Orchard Healthcare Research, Skokie
Local Institution - 005-110, Evanston
Healthcare Research Network - Tinley Park, Tinley Park
Local Institution - 005-198, Niles
Kansas City Care Health Center - Research Medical Campus, Kansas City
Central Care Cancer Center - Bolivar, Bolivar
Local Institution - 005-169, Westwood
Local Institution - 005-305, Strasbourg
Local Institution - 005-098, Wichita
Local Institution - 005-306, Mulhouse
Methodist Hospital - Omaha, Omaha
Saint Francis Cancer Treatment Center, Grand Island
Local Institution - 005-317, Lyon
Local Institution - 005-310, Bron
Local Institution - 005-602, Bari
Local Institution - 005-309, Le Mans
Local Institution - 005-174, Jonesboro
NEA Baptist Fowler Family Center for Cancer Care, Jonesboro
Highlands Oncology Group - Springdale, Springdale
Local Institution - 005-608, Lecce
Local Institution - 005-088, Oklahoma City
Local Institution - 005-406, Esslingen am Neckar
Local Institution - 005-410, Löwenstein
Local Institution - 005-302, Paris
USOR - Texas Oncology Northeast Texas - Denison, Denison
USOR - US Oncology Investigational Products Center, Irving
Local Institution - 005-125, McKinney
Local Institution - 005-128, Dallas
Local Institution - 005-129, Dallas
Local Institution - 005-126, Dallas
USOR - Texas Oncology Northeast Texas - Cancer and Research Institute - Tyler, Tyler
Local Institution - 005-314, Rouen
The Center for Cancer & Blood Disorders - Fort Worth, Fort Worth
Local Institution - 005-124, Denton
Oncology Consultants - Texas Medical Center, Houston
Local Institution - 005-076, Houston
Millennium Research and Clinical Development, Houston
USOR - Texas Oncology - Sugar Land, Sugar Land
Local Institution - 005-075, Beaumont
Texas Oncology - San Antonio Medical Center, San Antonio
Local Institution - 005-134, Austin
Local Institution - 005-097, Lafayette
Local Institution - 005-604, Napoli
Local Institution - 005-413, München
Local Institution - 005-402, München
Local Institution - 005-403, Gauting
Local Institution - 005-191, Coeur d'Alene
Local Institution - 005-504, Beersheba
Palo Verde Cancer Specialists - Glendale, Glendale
Yuma Regional Medical Center, Yuma
The Oncology Institute of Hope & Innovation - Tucson, Tucson
Local Institution - 005-308, Limoges
Local Institution - 005-411, Immenstadt im Allgäu
The Oncology Institute of Hope & Innovation - Henderson, Henderson
Local Institution - 005-152, Henderson
Los Angeles Hematology Oncology Medical Group, Los Angeles
Local Institution - 005-185, Los Angeles
Local Institution - 005-118, Beverly Hills
Local Institution - 005-192, Torrance
Local Institution - 005-105, Whittier
Cancer and Blood Specialty Clinic, Los Alamitos
Local Institution - 005-096, Long Beach
Local Institution - 005-109, Northridge
Local Institution - 005-090, West Covina
Local Institution - 005-176, San Marcos
Local Institution - 005-177, Redlands
Local Institution - 005-112, Riverside
Local Institution - 005-072, Newport Beach
Providence Medical Foundation - Virginia K. Crosson Cancer Center - Fullerton, Fullerton
Comprehensive Blood and Cancer Center - Bakersfield, Bakersfield
Local Institution - 005-171, Fresno
Local Institution - 005-311, Créteil
University of California San Francisco, San Francisco
Local Institution - 005-304, Villejuif
Local Institution - 005-603, Catania
Straub Medical Center, Honolulu
Providence Portland Medical Center, Portland
Local Institution - 005-073, Portland
Overlake Medical Center and Clinics, Bellevue
Local Institution - 005-082, Everett
Local Institution - 005-081, Tacoma
Northwest Medical Specialties - Tacoma, Tacoma
Local Institution - 005-136, Vancouver
Local Institution - 005-187, Spokane
Local Institution - 005-400, Bad Berka
Local Institution - 005-505, Zsfat
Local Institution - 005-500, Afula
Local Institution - 005-506, Ramat Gan
Local Institution - 005-502, Holon
Local Institution - 005-501, Beer Yaakov
Local Institution - 005-507, Jerusalem
Eastern Connecticut Hematology and Oncology Associates, Norwich
Local Institution - 005-151, Chicago
New England Cancer Specialists - Scarborough, Scarborough
Local Institution - 005-178, Rockville
Local Institution - 005-159, Saint Louis Park
Local Institution - 005-142, Florham Park
Local Institution - 005-163, Little Silver
Cooperman Barnabas Medical Center, Livingston
Regional Cancer Care Associates - Sparta, Sparta
Local Institution - 005-111, Seattle
Centre Hospitalier Universitaire Universite Catholique de Louvain - Site Godinne, Yvoir
Local Institution - 005-259, Calgary
Local Institution - 005-250, Moncton
Saint John Regional Hospital, Saint John
Local Institution - 005-252, Hamilton
Local Institution - 005-251, Toronto
Local Institution - 005-257, Windsor
Local Institution - 005-255, Montreal
Saskatoon Cancer Centre, Saskatoon
Local Institution - 005-258, Québec
Local Institution - 005-408, Halle
Local Institution - 005-614, Roma
Local Institution - 005-700, 's-Hertogenbosch
Local Institution - 005-703, Amsterdam
Local Institution - 005-711, Amsterdam
Local Institution - 005-707, Breda
Local Institution - 005-713, Dordrecht
Local Institution - 005-702, Groningen
Local Institution - 005-712, Maastricht
Local Institution - 005-714, Nijmegen
Local Institution - 005-710, Rotterdam
Local Institution - 005-705, Rotterdam
Local Institution - 005-709, The Hague
Local Institution - 005-701, Utrecht
Local Institution - 005-708, Utrecht
Local Institution - 005-706, Zwolle
Local Institution - 005-800, Badalona
Local Institution - 005-822, Barcelona
Local Institution - 005-811, Barcelona
Local Institution - 005-810, Barcelona
Velindre University NHS Trust, Cardiff
Local Institution - 005-904, Cornwall
University Hospitals of Leicester NHS Trust, Leicester
Local Institution - 005-908, London
Local Institution - 005-900, London
The Royal Marsden NHS Foundation Trust, London
The Christie NHS Foundation Trust, Manchester
Local Institution - 005-903, Middlesex
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Mirati Therapeutics Inc.
INDUSTRY